Harpoon Therapeutics, Inc
4000 Shoreline Court, Suite 250
South San Francisco
CA
94080
United States
127 articles about Harpoon Therapeutics, Inc
-
Harpoon Therapeutics Expands Management Team
10/26/2017
Harpoon Therapeutics announced today that it has appointed Susan Dana Jones, Ph.D., to the position of senior vice president, product development and Rachael Lester to VP, corporate development.
-
Arix Bioscience Gets in on Bay Area Cancer Biotech Harpoon's $45 Million Funding Round
5/25/2017
-
Isogenica Limited Announces Renewal Of Licence Agreement By Harpoon Therapeutics
5/23/2017
-
Harpoon Therapeutics Appoints Che-Leung Law, Ph.D., As Vice President, Translational Medicine
5/4/2017
-
Harpoon Therapeutics Release: Biotech Appoints William E. Picht, Jr. As Chief Financial Officer
1/26/2017
-
Bay Area's Harpoon Therapeutics Taps Former Kolltan Pharma Exec as New CEO
12/14/2016
-
Harpoon Therapeutics Appoints Hans-Peter Gerber, PhD, as Chief Scientific Officer
11/8/2016